{"nct_id":"NCT02929498","title":"Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)","status":"TERMINATED","status_verified_date":"2019-04","start_date":"2017-07-31","start_date_type":"ACTUAL","primary_completion_date":"2018-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-31","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}